Cipla launches Spirofy for early diagnosis for COPD Ruchika Sharma17 Nov 2021 1:03 PM ISTMumbai: Pharma major, Cipla Limited, announced the launch of Spirofy, India's first pneumotach based portable, wireless Spirometer, on World COPD...
Cipla to be listed in Dow Jones Sustainability Index for emerging markets Ruchika Sharma16 Nov 2021 12:00 PM ISTMumbai: Cipla Limited has recently announced that the company has been selected in the S&P Dow Jones Sustainability Index (DJSI) for the Emerging...
Cipla resolves funding dispute with Pulmatrix over asthma drug Pumazole Ruchika Sharma12 Nov 2021 1:31 PM ISTPulmazole is an inhaled iSPERSE formulation of the antifungal drug itraconazole for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in...
Cipla unit gets termination notice on Rs 1560 crore acquisition deal with Avenue Therapeutics Hina Zahid5 Nov 2021 6:11 PM ISTIn November 2018, Cipla had announced that InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US based speciality business...
Eli Lilly, Cipla ink pact for Humalog,Trulicity to treat diabetes Ruchika Sharma4 Oct 2021 2:05 PM ISTNew Delhi: Eli Lilly and Company (India) Pvt. Ltd., is a wholly owned subsidiary of Eli Lilly and Company, a global biopharmaceutical...
Cipla eyes acquisitions after Covid windfall: Bloomberg Ruchika Sharma2 Oct 2021 9:30 AM ISTNew Delhi: Cipla Ltd., one of India's largest drugmakers, has built up a war chest and is on the prowl for deals that can boost growth beyond the...
Cipla, Kemwell Biopharma collaborate to develop, commercialize biosimilars Ruchika Sharma26 Aug 2021 10:00 AM ISTMumbai: Cipla Limited, a global pharmaceutical company and Kemwell Biopharma Private Limited, a biopharmaceutical Contract Development and...
Cipla bags USFDA nod for generic version of Durezol Ruchika Sharma12 Aug 2021 2:15 PM ISTMumbai: Drug major, Cipla Limited, today announced that the company has received final approval for its Abbreviated New Drug Application (ANDA) for...
Cipla recalls Solifenacin Succinate tablets in US over manufacturing issues Ruchika Sharma26 July 2021 1:30 PM ISTNew Delhi: Drug major Cipla is recalling 7,228 bottles of Solifenacin Succinate tablets, a medicine used to treat overactive bladder, in the US market...
Cipla gets DCGI nod to import Moderna COVID vaccine Farhat Nasim30 Jun 2021 5:15 PM ISTNew Delhi: In a breakthrough, the Drugs Controller General of India (DCGI) on Tuesday has granted permission to Cipla to import Moderna's Covid-19...
Cipla gets USFDA nod for generic version of Brovana Ruchika Sharma23 Jun 2021 11:00 AM ISTMumbai: Drug major, Cipla Limited, today announced that the company has received final approval for its Abbreviated New Drug Application...
Cipla says close to committing USD 1 billion to Moderna for COVID booster shot Ruchika Sharma1 Jun 2021 11:00 AM ISTNew Delhi: Seeking fast-track approvals to bring Moderna's single-dose Covid-19 booster vaccine in India expeditiously, Cipla has requested the...
